ACAMS Translates CAMS® into German and Announces Training Partnership with Frankfurt School of Finance & Management
The Association of Certified Anti-Money Laundering Specialists (ACAMS) is pleased to announce two strategic initiatives to support anti-financial crime professionals in Germany.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171128005211/en/
As part of its continued European expansion and ongoing commitment to developing ACAMS’ member services throughout the region, ACAMS’ globally recognized certified anti-money laundering specialist (CAMS®) accreditation program has been translated into German and will be launched at Frankfurt School Verlag’s Risiko Geldwäsche 2017 conference on November 29, 2017. CAMS® is widely regarded as a leader in the area of anti-money laundering certifications and recognized internationally by financial institutions, governments and regulators.
ACAMS and Frankfurt School of Finance & Management (Frankfurt School) are also pleased to announce the formation of a strategic training partnership to support AML professionals in Germany preparing for the CAMS® qualification. Frankfurt School’s inaugural CAMS® in German preparation training course will be held on March 21, 2018 with the first course graduates expected to take the examination at official testing centers across Germany in April.
“We are delighted to enter into partnership with such a prestigious business school as Frankfurt School Verlag and to include them in ACAMS’ network of international training partners,” said Angela Salter, ACAMS’ head of Europe. “We look forward to working closely with Frankfurt School to strengthen professionals’ international anti-money laundering expertise through CAMS® in German.”
“AML and financial crimes are global issues, and providing a globally recognized qualification, alongside local regulatory education, is very important to ACAMS,” added Salter. “We continue to invest in growing services for ACAMS members throughout Europe and know that organizations want their AML/CTF/CDD and sanctions professionals to have a guaranteed level of competence evidenced by a robust global qualification. The German-speaking, anti-financial crime community is a very important market for ACAMS and this widens the global appeal of CAMS®. ACAMS is proud to offer CAMS in a total of 11 languages.”
“As one of Europe’s leading international business schools specializing in finance and compliance, we’re delighted that the Frankfurt School will now offer training for the globally recognized CAMS® certification in German and English,” said Ms. Tina Vangelista, head of competence center governance and audit, professional and executive education, Frankfurt School. “This will sit alongside our established compliance and AML programming and confirms Frankfurt School’s commitment to delivering innovative and high-quality training that complements our well-established certification ‘Certified Compliance Professional’ (CCP).”
About Adtalem Global Education
The purpose of Adtalem Global Education is to empower students to achieve their goals, find success, and make inspiring contributions to our global community. Adtalem Global Education Inc. (NYSE: ATGE; member S&P MidCap 400 Index) is a leading global education provider and the parent organization of Adtalem Educacional do Brasil, American University of the Caribbean School of Medicine, Association of Certified Anti-Money Laundering Specialists, Becker Professional Education, Carrington College, Chamberlain University, DeVry University and its Keller Graduate School of Management, Ross University School of Medicine and Ross University School of Veterinary Medicine. For more information, please visit adtalem.com.
About the Association of Certified Anti-Money Laundering Specialists® (ACAMS®)
ACAMS is a member of Adtalem Global Education (NYSE: ATGE), a global education provider headquartered in the United States. The organization's purpose is to empower students to achieve their goals, find success and make inspiring contributions to our global community. ACAMS is the largest international membership organization dedicated to enhancing the knowledge and skills of anti-money laundering (AML) and financial crime professionals from a wide range of industries, with extensive resources designed to develop and sharpen the skills required for superior job performance and career advancement. Its CAMS certification is the most widely recognized AML certification among compliance professionals worldwide. Visit acams.org for more information. In addition to English, ACAMS also offers CAMS® in Arabic, Bahasa Indonesian, Chinese, Simplified Chinese, French, German, Japanese, Portuguese, Russian and Spanish.
About the Frankfurt School of Finance & Management
Frankfurt School of Finance & Management is a research-led business school accredited by EQUIS and AACSB International. Frankfurt School offers educational program covering financial, economic and management subjects, including Bachelor and Master degrees, various MBAs and a doctoral program, executive education, certified courses of study, open seminars and training courses for professionals, as well as seminars and workshops for those in vocational training. In their research, the members of Frankfurt School’s faculty explore topical aspects of business, management, banking and finance. Frankfurt School experts also manage advisory and training projects on financial matters in emerging markets and developing countries, especially on topics related to microfinance and renewable energy finance. Frankfurt School’s Master of Finance program is the only German-language Master degree in finance to appear in the current Financial Times ranking (at number 28 in June 2017). In the latest ranking of German-language higher-education program by German weekly business magazine Wirtschaftswoche, Frankfurt School ranked seventh in the Business Studies category. In addition to its campus in Frankfurt, Frankfurt School has study centers in Hamburg and Munich, as well as international offices in Ankara (Turkey), Beijing (China), Mumbai (India) and Nairobi (Kenya). It is a globally connected business school with over 125 partner universities. For more details see www.frankfurt-school.de .
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Andersen Global Expands Presence in Germany with Addition of Thierhoff Müller & Partner13.12.2017 11:01 | Tiedote
Andersen Global is proud to announce an expanded presence in Germany as Thierhoff Müller & Partner, a tax and legal firm with offices in Leipzig and Frankfurt, combines its practice with Andersen Tax & Legal in Germany. Through its German member firms, Andersen Tax & Legal and Alegis Steuerberatungsgesellschaft mbH, Andersen Global now has more than 65 professionals focused on providing tax and legal services and business advice across five locations in Germany, including Cologne, Dusseldorf, and Merzig. “Thierhoff Müller is highly regarded in complex restructuring matters. Together with our existing legal and tax practice, we will be able to increase our service offerings for our clients,” said Stefan Kraus, Managing Partner of Andersen Tax & Legal in Germany. “We are dedicated to providing outstanding service and are adding additional competencies in tax and legal such as corporate r
Aprecia Pharmaceuticals and Cycle Pharmaceuticals Partner to Develop 3D-Printed Orphan Drugs13.12.2017 11:00 | Tiedote
Aprecia Pharmaceuticals, LLC (“Aprecia”), The 3DP Pharmaceutical Company, and Cycle Pharmaceuticals, Ltd. (“Cycle”) today announced they have signed a partnership agreement to develop and commercialize orphan drugs using three-dimensionally printed (“3DP”) technology. The planned products will deliver quality-of-life improvements versus existing, approved orphan drugs, and will achieve this by utilizing Aprecia’s proprietary 3DP ZipDose® Technology platform. ZipDose® is the only three-dimensional printing technology used in a pharmaceutical drug product approved by the U.S. Food and Drug Administration. Antonio Benedetti, CEO of Cycle commented: “Many rare disease patients do not have a treatment option at all. For those rare diseases where there is an approved pharmaceutical treatment, patients continue to be burdened by sub-optimal drug formulations. Aprecia’s
Group Vivendi Africa Deploys Netcracker OSS to Enhance Service Management as it Expands Across the Continent12.12.2017 19:07 | Tiedote
Netcracker Technology announced today that its OSS suite was selected and deployed to support the long-term growth strategy of Group Vivendi Africa (GVA). GVA is a newly formed affiliate of the French-based multinational conglomerate Vivendi with the goal to deploy and operate a fiber network across Africa. Netcracker's OSS will be used as a consolidated solution to identify service availability across GVA's operating countries and then fulfill and provision those services to customers. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171212005937/en/ Netcracker's highly productized, out-of-the-box applications enabled the OSS suite to be deployed in seven months, meeting GVA's demand to leverage an integrated service fulfillment and inventory solution that could satisfy its long-term growth expectations, as well as s
Philip Morris International Releases Latest Scientific Update for Smoke-Free Products on Clinical Program12.12.2017 18:23 | Tiedote
Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today released its latest Scientific Update for Smoke-Free Products, a regular publication on its research efforts to develop and assess a range of smoke-free alternatives to cigarettes. The latest issue of the Scientific Update can be found at this link. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171212005891/en/ Philip Morris International Releases Latest Scientific Update for Smoke-Free Products on Clinical Program (Photo: Business Wire) This issue of the Scientific Update provides a closer look at some of the principles and practices on which PMI’s scientific assessment program is built. Director Medical Affairs Dr. Patrick Picavet describes specific examples from PMI’s clinical program that highlight the company’s
Murex to Offer MX.3 Risk, Trading and Post-Trade Solutions on the AWS Cloud12.12.2017 17:00 | Tiedote
Murex, an industry leader in trading, risk management and processing solutions for capital markets, announced they will run their MX.3 technology platform on Amazon Web Services, Inc. (AWS). With the acceleration of cloud adoption in capital markets, Murex and AWS agreed to collaborate to help clients migrate their Murex application workloads to the AWS Cloud. Murex clients are looking to consolidate more and more of their capital markets activity on the MX.3 platform and this means their need for infrastructure is increasing. New regulatory requirements are also driving financial organizations to use cloud to scale up their computing capacity. Murex is collaborating with AWS to meet the demand from clients to support deployment of the Murex offering on the AWS Cloud. Murex is working on the validation of a range of deployment scenarios, from using AWS Cloud for bursting grid
Darzalex®▼(daratumumab) Combination Regimen Significantly Improved Outcomes for Newly Diagnosed Multiple Myeloma Patients who are Transplant Ineligible12.12.2017 16:33 | Tiedote
Janssen-Cilag International NV (“Janssen”) today announced data from the Phase 3 ALCYONE study, showing Darzalex® (daratumumab) in combination with bortezomib, melphalan and prednisone (VMP) significantly improved clinical outcomes, including reducing the risk of disease progression or death by 50 percent, in patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation (ASCT).1 These data were accepted as a late-breaking abstract (LBA) for presentation at the 59th American Society of Hematology (ASH) Annual Meeting in Atlanta, today at 7:30 a.m. ET (Abstract #LBA-4).1 Study findings were simultaneously published in the New England Journal of Medicine (NEJM) . 2 Daratumumab is currently indicated for use in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme